Condition: Infertility · Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
The purpose of this study is to assess the efficacy and safety of follitropin alfa/lutropin alfa in Japanese participants with Luteinizing hormone (LH) and Follicle stimulating hormone (FSH) deficiency undergoing Assisted reproductive technology (ART). The study duration is approximately 5.5 months for nonpregnant participants and 13 months for participants with confirmed pregnancy in Part A.
This description comes directly from the study's public registry record.
Communication Center · +49 6151 72 5200 · service@emdgroup.com
Always discuss trial participation with your own doctor first.
| Akita University Hospital - Dept of Obstetrics/Gynecology | Akita, Akita, Japan | Recruiting |
| Kameda IVF Clinic Makuhari - Dept of Obstetrics/Gynecology | Chiba, Chiba, Japan | Recruiting |
| YOKOTA Maternity Hospital - Dept of Reproductive Medical Gynecology | Maebashi, Gunma, Japan | Recruiting |
| Kamiya Ladies Clinic - Dept of Gynecology | Sapporo, Hokkaido, Japan | Recruiting |
| Hanabusa Women's Clinic Hanabusa Women's Central Fertility Clinic - Dept of Obstetrics/Gynecology | Kobe, Hyōgo, Japan | Recruiting |
| Sophia Ladies Clinic - Dept of Obstetrics/Gynecology | Sagamihara-shi, Kanagawa, Japan | Recruiting |
| Ladies Clinic Cosmos - Dept of Infertility Treatment | Kochi, Kochi, Japan | Recruiting |
| Nagano Municipal Hospital - Dept of Gynecology | Nagano, Nagano, Japan | Recruiting |
| JA-Nagano Shinonoi General Hospital - Dept of Obstetrics/Gynecology | Nagano, Nagano, Japan | Recruiting |
| Sora no Mori Clinic - Dept of Obstetrics/Gynecology | Shimajiri-gun, Okinawa, Japan | Recruiting |
| Sankeikai IVF Osaka Clinic - Dept of Obstetrics/Gynecology | Higashiosaka-shi, Osaka, Japan | Recruiting |
| Haruki Ladies Clinic - Dept of Gynecology | Osaka, Osaka, Japan | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07340827